ZERO: The End of Prostate Cancer meets the 20 Standards for Charity Accountability.
ZERO: The End of Prostate Cancer (ZERO) reports that it offers direct support for prostate cancer patients and families, including customized case management, peer-to-peer mentorship, transportation, online resources, and a nationwide network of local support groups. Case managers help patients access financial resources, assist with insurance and Medicare issues, and find emotional support. The organization supplies educational information, operates awareness campaigns, and advocates at the federal, state, and community level for more funding for prostate cancer research. ZERO states that it also provides financial grants for men with advanced prostate cancer who cannot afford treatment. In 2020, the organization reports that it served more than 766,000 patients and caregivers through its programs and informational materials, provided more than 2,300 patients with one-on-one support, and distributed 13 research, education, and support grants.
For the year ended March 31, 2021, ZERO: The End of Prostate Cancer's program expenses were:
Education and awareness |
$3,181,171 |
Advocacy |
$636,528 |
Patient support |
$309,137 |
Research |
$115,980 |
Total Program Expenses: |
$4,242,816 |
-
Chief Executive
Jamie Bearse, President and Chief Executive Officer
-
Compensation*
$264,925
-
Chair of the Board
Thomas Bognanno
-
Chair's Profession / Business Affiliation
President and Chief Executive Officer, Community Health Charities
-
Board Size
15
-
Paid Staff Size
56
*2020 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Invitations to fund raising events, Planned giving arrangements, Telephone appeals, Cause- related marketing (affinity credit cards, consumer product sales, etc.)
Fundraising costs were 7% of related contributions. (Related contributions, which totaled $6,637,137 are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on ZERO: The End of Prostate Cancer's audited financial statements for the year ended March 31, 2021.
Source of Funds |
Grants and contributions |
$6,573,728 |
Investment income, net |
$417,579 |
Program service revenue |
$64,391 |
Special events |
$63,409 |
Merchandise sales |
$5,037 |
Total Income |
$7,124,144 |
- Programs: 86%
- Fundraising: 9%
- Administrative: 5%
Total Income |
$7,124,144 |
Program expenses |
$4,242,816 |
Fundraising expenses |
$487,881 |
Administrative expenses |
$255,656 |
Other expenses |
$0 |
Total expenses: |
$4,986,353 |
Income in Excess of Expenses |
$2,137,791 |
Beginning Net Assets |
$2,642,362 |
Other Changes In Net Assets |
$0 |
Ending Net Assets |
$4,780,153 |
Total Liabilities |
$1,281,315 |
Total Assets |
$6,061,468 |